Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma
The SSR4 gene may have significant relevance with clinical pathological factors, and play a critical role in the regulation of tumor microenvironment of ESCC patients. Overall, SSR4 may be a promising ESCC biomarker with prospective applicability in clinical diagnosis as well as the development of targeted treatment approaches in patients of ESCC.
Authors
- Fang Jia (ORCID: https://orcid.org/0000-0002-7738-8491)
- Chuqiao Li (ORCID: https://orcid.org/0000-0002-5052-4780)
- Jiaqi Zhang (ORCID: https://orcid.org/0000-0002-3417-1508)
- Aixia Gong (ORCID: https://orcid.org/0000-0003-0427-3674)
- Shunzhe Song (ORCID: https://orcid.org/0000-0002-7407-7436)
Institutions
- Dalian Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fimmu.2025.1544154
- Citations
- 3
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 6.02